Amphastar Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

• Amphastar Pharmaceuticals Inc AMPH.OQ reported quarterly adjusted earnings of 96 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $1.15. The mean expectation of five analysts for the quarter was for earnings of 99 cents per share. Wall Street expected results to range from 89 cents to $1.13 per share.

• Revenue rose 5.9% to $191.21 million from a year ago; analysts expected $194.69 million.

• Amphastar Pharmaceuticals Inc's reported EPS for the quarter was 78 cents​.

• The company reported quarterly net income of $40.43 million.

• Amphastar Pharmaceuticals Inc shares had risen by 6.2% this quarter and lost 16.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.8% in the last three months.​

• In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Amphastar Pharmaceuticals Inc is $55.00

This summary was machine generated from LSEG data November 7 at 04:04 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)